Vsee Health (NASDAQ:VSEE) Now Covered by Maxim Group

Equities research analysts at Maxim Group initiated coverage on shares of Vsee Health (NASDAQ:VSEEGet Free Report) in a note issued to investors on Monday,Briefing.com Automated Import reports. The firm set a “buy” rating and a $5.00 price target on the stock. Maxim Group’s price objective indicates a potential upside of 174.73% from the company’s current price.

Vsee Health Stock Performance

Shares of Vsee Health stock opened at $1.82 on Monday. Vsee Health has a twelve month low of $1.12 and a twelve month high of $33.08. The company has a current ratio of 0.37, a quick ratio of 0.37 and a debt-to-equity ratio of 0.16. The business’s fifty day moving average price is $1.54 and its 200 day moving average price is $1.59.

Institutional Inflows and Outflows

A hedge fund recently raised its stake in Vsee Health stock. Geode Capital Management LLC boosted its position in Vsee Health, Inc. (NASDAQ:VSEEFree Report) by 56.0% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 67,549 shares of the company’s stock after acquiring an additional 24,245 shares during the quarter. Geode Capital Management LLC owned 1.87% of Vsee Health worth $92,000 as of its most recent filing with the Securities and Exchange Commission. 1.01% of the stock is owned by institutional investors and hedge funds.

Vsee Health Company Profile

(Get Free Report)

VSee Health, Inc is a no-code or low-code software as a service (SaaS) platform that enables clinicians and enterprises to create their telehealth workflows without programming. It engages in providing timely, quality healthcare to patients regardless of geographical barriers. The company is headquartered in Boca Raton, FL.

Featured Stories

Receive News & Ratings for Vsee Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Vsee Health and related companies with MarketBeat.com's FREE daily email newsletter.